Skip to content
Home/Companies/Biotech/Precirix

Precirix

Biotech·France·Active·8yr hold
Entry
2018
Hold
8yr
Status
Active

Who owns Precirix?

Precirix is a French Biotech company, currently owned by HealthCap since 2018.

Hand-verified · updated 2026-09-30

Open JSON · CC-BY
HealthCap
Most recent investor
HealthCap
HealthCap VII · 2016 · VC
2 ownership periods · full history below

Key facts

HQFrance
SectorBiotech

Ownership history

2 ownership periods · co-invest detected

Active
Currently held by HealthCap since 2018.
Co-invest · 2 holders · 2018 · present
HealthCap
HealthCapActive
2018 · present(8yr) · HealthCap VII · 2016 · VC
Jeito Capital
Jeito CapitalExited 2026
2022 · 2026(4yr) · Jeito I · 2021 · VC

Jeito Capital exited Precirix in 2026 after 4 years.

More from HealthCap VII

Other portfolio companies in the same fund.

Mahzi Therapeutics
Active
BiotechUS· 2020
Priothera Ltd.
Active
BiotechIreland· 2020
SynOx Therapeutics Ltd
Active
BiotechIreland· 2020
Carisma Therapeutics
Exited 2023
BiotechUS· 2018
to Sesen Bio, Inc.
InCarda Therapeutics Inc.
Active
BiotechUS· 2018
Modus Therapeutics
Modus Therapeutics
Active
BiotechSweden· 2018

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Abbisko Healthcare
Active
The Carlyle GroupChina
Adagene
Active
General AtlanticChina
Advanced Cell Diagnostics
Active
Summit PartnersUS
Akero Therapeutics
Akero Therapeutics
Active
General AtlanticUS
Aldevron
Aldevron
Active
TA AssociatesUS
Alloy Therapeutics
Alloy Therapeutics
Active
Mubadala CapitalUS

Questions

Who owns Precirix?

Precirix is currently owned by HealthCap, through HealthCap VII, since 2018.

When did HealthCap acquire Precirix?

HealthCap acquired Precirix in 2018.

Who has owned Precirix over time?

Precirix has been through 2 private-equity ownership periods: HealthCap · via HealthCap VII · since 2018; Jeito Capital · via Jeito I · 2022–2026.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue